For citations:
Kolbin А.S., Kurylev А.А., Balykina Yu.Е., Proskurin М.А., Mishinova S.А. Health economic evaluation of risdiplam in patients with spinal muscular atrophy. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2021;14(3):299-310. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2021.101

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.